PMID: 9418768Jan 7, 1998Paper

Terbinafine: an update

Journal of the American Academy of Dermatology
A K Gupta, N H Shear

Abstract

Oral terbinafine was first introduced in the United Kingdom in February 1991 and was approved for the treatment of onychomycosis in the United States in May 1996. It is estimated that 4 million patients worldwide have been treated with oral terbinafine as of December 1996. The efficacy of terbinafine in the treatment of onychomycosis and other dermatomycoses is reviewed. The adverse-effects profile of oral terbinafine is evaluated.

References

Feb 1, 1992·The British Journal of Dermatology·J G van der SchroeffJ Wuite
Feb 1, 1992·The British Journal of Dermatology·N S Ryder
Feb 1, 1991·Journal of the American Academy of Dermatology·R J HayY M Clayton
Jan 1, 1989·European Journal of Clinical Pharmacology·A Wahlländer, G Paumgartner
Mar 1, 1989·Clinical and Experimental Dermatology·J C Jensen
Mar 1, 1989·Clinical and Experimental Dermatology·R Savin
Sep 1, 1987·Antimicrobial Agents and Chemotherapy·G PetranyiH Mieth
May 1, 1995·Clinical and Experimental Dermatology·P ToddD D Munro
Jul 1, 1994·Journal of Hepatology·J W van 't WoutB H Stricker
Mar 1, 1994·Journal of the American Academy of Dermatology·B RzanyE Schöpf
Apr 1, 1994·The British Journal of Dermatology·L Gip
Jan 23, 1993·BMJ : British Medical Journal·G LoweP Jennings
Sep 1, 1995·Clinical and Experimental Dermatology·F SchatzA Stütz
Jul 1, 1996·Journal of the American Academy of Dermatology·M D DesgarennesA B Palencia
Jun 1, 1996·The British Journal of Dermatology·R NandwaniD A Hawkins
Jun 1, 1996·The British Journal of Dermatology·P EsterreP Roig
Jan 1, 1996·Dermatology : International Journal for Clinical and Investigative Dermatology·E K Van DoorslaerE Haneke
Dec 1, 1996·The British Journal of Dermatology·F Baudraz-RosseletE Frenk
Mar 8, 1996·PharmacoEconomics·T R EinarsonS Arikian

❮ Previous
Next ❯

Citations

Aug 14, 2001·Pharmacoepidemiology and Drug Safety·E P van PuijenbroekH G Leufkens
Feb 24, 2009·Applied Microbiology and Biotechnology·Wenliang ZhangQi Jin
Dec 8, 1998·Journal of the American Academy of Dermatology·D L Ornstein, P Ely
Oct 12, 2000·Clinics in Dermatology·R A Johnson
Sep 26, 2012·The Journal of Organic Chemistry·Rakesh Kumar, Barbara Zajc
Oct 9, 1999·International Journal of Dermatology·J E ArreseG E Piérard
Oct 9, 1999·International Journal of Dermatology·A K Gupta, J Lambert
Aug 12, 2000·International Journal of Dermatology·A K GuptaH Degreef
Aug 16, 2002·Letters in Applied Microbiology·E M F RochaN M Martinez-Rossi
Sep 16, 1998·The Australasian Journal of Dermatology·A K Gupta, A J Porges
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·Mahboubeh Hosseini-Yeganeh, Andrew J McLachlan
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Marcia A S GraminhaNilce M Martinez-Rossi
Aug 12, 2000·Drugs & Aging·A K Gupta
Jul 27, 2011·Medical Mycology Journal·Takashi Harada
Nov 30, 2000·Current Infectious Disease Reports· Del Rosso JQ
Jul 2, 2005·Expert Opinion on Emerging Drugs·Sevtap Arikan, John H Rex
Jan 15, 2016·Expert Opinion on Investigational Drugs·Aditya K Gupta, Catherine Studholme
Jan 9, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sakine Tuncay Tanrıverdi, Özgen Özer
Apr 24, 2010·International Journal of Pharmaceutics·Vishal SachdevaAjay K Banga
Dec 21, 2005·The Veterinary Clinics of North America. Small Animal Practice·Stephanie R Bruner
Jul 20, 1999·Journal of the American Academy of Dermatology·B Krafchik, J Pelletier
Aug 30, 2005·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Kuo-Ching YangYuan-Soon Ho
Aug 13, 2003·The Veterinary Clinics of North America. Small Animal Practice·Amy M Grooters, Joseph Taboada
Mar 11, 1998·Lancet·A K Gupta, R K Scher
Apr 14, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sara M AbdelSamieShady M Ibrahim
Jan 22, 2002·Best Practice & Research. Clinical Obstetrics & Gynaecology·H A Shehata, C Nelson-Piercy
Sep 25, 2001·Journal of the American Academy of Dermatology·C Aguilar, K K Mueller
Aug 19, 2005·Expert Review of Anti-infective Therapy·Adolfo C Fernandez-ObregonCarolyn Willis
Mar 15, 2000·The Australasian Journal of Dermatology·A P Hall, B Tate
Jun 9, 2004·International Journal of Cancer. Journal International Du Cancer·Pei-Yin HoWen-Sen Lee
Jun 10, 2003·International Journal of Cancer. Journal International Du Cancer·Wen-Sen LeeYuan-Soon Ho
Jan 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A K Gupta, N H Shear
Dec 2, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·David FarhiHervé Bachelez
Apr 3, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·Aditya K GuptaBianca Maria Piraccini
Jan 29, 2000·Postgraduate Medicine·R T Brodell, B Elewski
Oct 21, 2003·The Annals of Pharmacotherapy·Burhan A AksakalMehmet Ali Gürer
Nov 13, 2001·American Journal of Clinical Dermatology·B E Elewski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.